X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Potential of Self-Driving Labs – New Proposed Guidelines

Content Team by Content Team
20th February 2024
in IPR Data Management, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The fields within chemistry as well as materials science are seeing an increase in interest in self-driving labs that go on make use of artificial intelligence- AI as well as automated systems to speed up research and discovery. Researchers happen to be now looking to propose a suite of definitions and performance metrics that will enable themselves, non-experts, as well as future users to better gauge what such new technologies happen to be doing in addition to how each technology would perform vis-à-vis other self-driving labs. Their inferences have gone on to be published in Nature Communications.

Self-driving labs hold a tremendous promise when it comes to accelerating the exploration of new molecules, materials, as well as manufacturing processes, by way of applications that range from electronic devices to pharmaceuticals. While technologies happen to be fairly new, some have gone on to show that they lessen the time required so as to identify fresh materials from months or years to even days.

Self-driving labs happen to be garnering immense attention as of now, however, there are immense outstanding questions with regards to these technologies, remarked the corresponding author of a paper on the new metrics and also an associate professor of chemical and biomolecular engineering at North Carolina State University, Milad Abolhasani. He adds that this technology is described as autonomous; however, different research teams happen to be defining autonomous in a varied way. By the same token, varied research teams are reporting distinct aspects of their work differently. This makes it a challenge to go ahead and even compare such technologies to each other, and the comparison is even more important if one wants to be able to comprehend each other and even push the field forward.

According to Milad Abolhasani, what does Self-Driving Lab A go ahead and do really well? How could one use that so as to improve the Self-Driving Lab B’s performance? They happen to be proposing a set of shared definitions along with performance metrics, which they hope will be embraced by everyone working within this space. The final objective will be to enable all to learn from each other as well as even advance such powerful research acceleration technologies.

For instance, one seems to be seeing some issues when it comes to self-driving labs that happen to be related to the performance, precision, as well as robustness of certain autonomous systems, says Abolhasani. This goes on to raise questions pertaining to how useful such technologies can be. If one happens to have standardized metrics as well as the reporting of results, one can identify such challenges and even better gauge how to address them.

At the core of the new proposal happens to be a clear definition of self-driving labs and seven proposed performance metrics, that researchers would go on to include in any published work that’s related to their self-driving labs.

• Degree when it comes to autonomy: how much guidance a system needs from users?

• Operational lifetime: how long can the system function without any intervention from users?

• Throughput: how long it takes the system to run one-single experiment?

• Experimental precision: how reproducible happen to be the results of the system?

• Material use: what is the total amount of materials that happen to be used by a system pertaining to each experiment?

• Parameter space that is accessible: to what extent would the system go on to account for all the variables across each experiment?

• Efficiency concerning optimization

Optimization efficiency happens to be one of the most significant of these metrics, but it is also one of the most intricate as it doesn’t lend itself to an exact definition, says Abolhasani. Essentially, one just wants the researchers to quantitatively assess the performance of the self-driving lab and its experiment-selection algorithm by setting standards against a baseline for instance, through random sampling.

At the end of the day, one thinks having a standardized approach in order to report on self-driving labs will enable to make sure that this field happens to be coming up with trustworthy, reproducible results that go on to make the most of AI programs that go ahead and capitalize on the large, high-quality sets of data that get produced by self-driving labs, says Abolhasani.

Previous Post

Lab Productivity To Be Enhanced By Digital Tools From Tecan

Next Post

Clinical Trials Automation: Step Towards Sustainable Pharma

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Clinical Trials Automation: Step Towards Sustainable Pharma

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In